Mental health FDA Approves Bysanti: Breakthrough Schizophrenia & Bipolar I Treatment February 27, 2026
Healthy Aging Breaking: FDA Approved Longevity Trial Begins for Life Biosciences' ER 100 February 24, 2026
Mental health COMP360 Psilocybin Phase 3 Results: A Historic Breakthrough for Depression Treatment in 2026 February 18, 2026
Mental health FDA Signals Green Light: New State 'Trigger Laws' Set to Fast-Track Psilocybin for PTSD February 08, 2026
Healthy Aging FDA Approves First Human Trial for Cellular Reprogramming to Reverse Vision Loss February 07, 2026
Healthy Aging Age Reversal Breakthrough: FDA Approves First Human Reprogramming Trials February 07, 2026
Healthy Aging FDA Approves Yuvezzi: The First Dual-Action Eye Drop to Reverse Presbyopia February 06, 2026
